Malignant ascites
(UMLS:C0220656)
- UMLS ID:
- C0220656
- MeSH ID:
- N/A
Synonym(s)
1.
Malignant ascites
2.
ASCITES MALIGNANT
3.
Ascites, Malignant
4.
Malignant Ascites
5.
Malignant ascites, NOS
6.
ascites, malignant
7.
ascites; malignant
8.
malignant ascites
9.
malignant peritoneal effusion
10.
malignant; ascites
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | gemcitabine | FAERS: 16 | US FAERS | |
| 2 | Sitagliptin Phosphate | FAERS: 12 | US FAERS | |
| 3 | Topotecan | FAERS: 6 | OFFSIDES US FAERS | |
| 4 | Capecitabine | FAERS: 4 | OFFSIDES US FAERS | |
| 5 | Paclitaxel | FAERS: 4 | US FAERS | |
| 6 | Sorafenib | FAERS: 4 | US FAERS | |
| 7 | Erlotinib Hydrochloride | FAERS: 3 | US FAERS | |
| 8 | Everolimus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 9 | Leucovorin | FAERS: 3 | US FAERS | |
| 10 | Afatinib | FAERS: 2 | US FAERS | |
| 11 | Bortezomib | FAERS: 2 | US FAERS | |
| 12 | Diclofenac | FAERS: 2 | US FAERS | |
| 13 | Octreotide | FAERS: 2 | US FAERS | |
| 14 | Tiotropium Bromide | FAERS: 2 | US FAERS | |
| 15 | Zoledronic Acid | FAERS: 2 | US FAERS | |
| 16 | pazopanib | FAERS: 2 | US FAERS | |
| 17 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 18 | Anastrozole | FAERS: 1 | US FAERS | |
| 19 | Bosentan | FAERS: 1 | US FAERS | |
| 20 | Cilostazol | FAERS: 1 | OFFSIDES US FAERS | |
| 21 | Docetaxel | FAERS: 1 | US FAERS | |
| 22 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 23 | Fulvestrant | FAERS: 1 | OFFSIDES US FAERS | |
| 24 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 25 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 26 | LCZ 696 | FAERS: 1 | US FAERS | |
| 27 | Lenalidomide | FAERS: 1 | US FAERS | |
| 28 | Meloxicam | FAERS: 1 | OFFSIDES US FAERS | |
| 29 | Memantine | FAERS: 1 | US FAERS | |
| 30 | Oxycodone | FAERS: 1 | US FAERS | |
| 31 | Paroxetine | FAERS: 1 | US FAERS | |
| 32 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 33 | Teriparatide | FAERS: 1 | US FAERS | |
| 34 | Ticagrelor | FAERS: 1 | US FAERS | |
| 35 | Vemurafenib | FAERS: 1 | US FAERS | |
| 36 | Vincristine | FAERS: 1 | US FAERS | |
| 37 | ceritinib | FAERS: 1 | US FAERS | |
| 38 | nintedanib | FAERS: 1 | US FAERS | |
| 39 | niraparib | FAERS: 1 | US FAERS | |
| 40 | olaparib | FAERS: 1 | US FAERS | |
| 41 | osimertinib | FAERS: 1 | US FAERS | |
| 42 | regorafenib | FAERS: 1 | US FAERS | |
| 43 | rucaparib | FAERS: 1 | US FAERS | |
| 44 | saxagliptin | FAERS: 1 | US FAERS | |
| 45 | temsirolimus | FAERS: 1 | US FAERS | |
| 46 | treprostinil | FAERS: 1 | US FAERS | |
| 47 | 5-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydron;chloride | OFFSIDES | ||
| 48 | Aspartic Acid | OFFSIDES | ||
| 49 | Axitinib | OFFSIDES | ||
| 50 | Bisacodyl | OFFSIDES | ||
| 51 | Cimetidine | OFFSIDES | ||
| 52 | Cyclophosphamide | OFFSIDES | ||
| 53 | Fluorouracil | OFFSIDES | ||
| 54 | Iopamidol | OFFSIDES | ||
| 55 | Leucovorin | OFFSIDES | ||
| 56 | Medroxyprogesterone | OFFSIDES | ||
| 57 | Nitroglycerin | OFFSIDES | ||
| 58 | Palonosetron | OFFSIDES | ||
| 59 | Piperacillin | OFFSIDES | ||
| 60 | Propionate | OFFSIDES | ||
| 61 | Sodium gualenate | OFFSIDES | ||
| 62 | Temozolomide | OFFSIDES | ||
| 63 | Tremorine | OFFSIDES | ||
| 64 | Triazolam | OFFSIDES | ||
| 65 | Urea | OFFSIDES | ||
| 66 | Vitamin K 2 | OFFSIDES | ||
| 67 | chlorhexidine gluconate | OFFSIDES | ||
| 68 | exemestane | OFFSIDES | ||
| 69 | fosfluconazole | OFFSIDES | ||
| 70 | itopride | OFFSIDES | ||
| 71 | mizoribine | OFFSIDES | ||
| 72 | ramosetron | OFFSIDES | ||
| 73 | reviparin | OFFSIDES | ||
| 74 | urapidil | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.